TABLE 4.
BC | MB | NB | NF | NS | ON | PE | QC | SK | |
---|---|---|---|---|---|---|---|---|---|
AB | ns | ns | 0.003 | 0.026 | ns | ns | ns | ns | ns |
BC | – | ns | 0.013 | ns | ns | ns | ns | ns | ns |
MB | – | – | 0.002 | 0.019 | ns | ns | ns | ns | ns |
NB | – | – | – | ns | ns | 0.005 | ns | 0.004 | 0.002 |
NF | – | – | – | – | ns | 0.038 | ns | 0.031 | 0.016 |
NS | – | – | – | – | – | ns | ns | ns | ns |
ON | – | – | – | – | – | – | ns | ns | ns |
PE | – | – | – | – | – | – | – | ns | ns |
QC | – | – | – | – | – | – | – | – | ns |
This table is a companion table to Figure 2B. BC British Columbia; MB Manitoba; NB New Brunswick; NF Newfoundland and Labrador; ns No significant difference in the prescribing rates between the two provinces; NS Nova Scotia; ON Ontario; PE Prince Edward Island; QC Quebec; SK Saskatchewan